000 01312 a2200313 4500
005 20250517052845.0
264 0 _c20151109
008 201511s 0 0 cze d
022 _a0862-495X
024 7 _a10.14735/amko20152s32
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aProcházková, I
245 0 0 _a[Polo-like Kinase 1 as a Target for Anti-tumor Therapy].
_h[electronic resource]
260 _bKlinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
_c2015
300 _a2S32-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCell Cycle Proteins
_xantagonists & inhibitors
650 0 4 _aDrug Discovery
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_xdrug therapy
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aProtein Serine-Threonine Kinases
_xantagonists & inhibitors
650 0 4 _aProto-Oncogene Proteins
_xantagonists & inhibitors
650 0 4 _aPolo-Like Kinase 1
700 1 _aVojtěšek, B
773 0 _tKlinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
_gvol. 28 Suppl 2
_gp. 2S32-9
856 4 0 _uhttps://doi.org/10.14735/amko20152s32
_zAvailable from publisher's website
999 _c25265268
_d25265268